These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 23044382)

  • 1. Promising immunotherapy technique.
    Fillon M
    J Natl Cancer Inst; 2012 Oct; 104(20):1528-9. PubMed ID: 23044382
    [No Abstract]   [Full Text] [Related]  

  • 2. [New era of tumor immunotherapy].
    Yoshitake Y; Nakatsura T; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapies in clinical trials: do they demand different evaluation tools?
    Tuma RS
    J Natl Cancer Inst; 2011 May; 103(10):780-1. PubMed ID: 21551417
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.
    Waldmann TA; Dubois S; Tagaya Y
    Immunity; 2001 Feb; 14(2):105-10. PubMed ID: 11239443
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy.
    Tomala J; Chmelova H; Mrkvan T; Rihova B; Kovar M
    J Immunol; 2009 Oct; 183(8):4904-12. PubMed ID: 19801515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 15 as a promising candidate for tumor immunotherapy.
    Jakobisiak M; Golab J; Lasek W
    Cytokine Growth Factor Rev; 2011 Apr; 22(2):99-108. PubMed ID: 21531164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive cellular immunotherapy of cancer.
    Winter H; Fox BA
    Curr Opin Mol Ther; 1999 Feb; 1(1):89-97. PubMed ID: 11249690
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor immunology top 10 list.
    Finn OJ
    Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in immunotherapy for pediatric cancer].
    Xu X; Zhao H; Tang Y
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):231-4. PubMed ID: 24824398
    [No Abstract]   [Full Text] [Related]  

  • 10. NK cells and Immunotherapy.
    Tian Z
    Semin Immunol; 2017 Jun; 31():1-2. PubMed ID: 28985906
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer immunotherapy.
    White RL; Amin A
    Surg Oncol Clin N Am; 2011 Jul; 20(3):531-54, ix. PubMed ID: 21640920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in immuno-oncology. Foreword.
    Eggermont A; Finn O
    Ann Oncol; 2012 Sep; 23 Suppl 8():viii5. PubMed ID: 22918929
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoclonal antibodies in cancer immunotherapy.
    Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C
    Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-15: targeting CD8+ T cells for immunotherapy.
    Diab A; Cohen AD; Alpdogan O; Perales MA
    Cytotherapy; 2005; 7(1):23-35. PubMed ID: 16040381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer treatment: The killer within.
    Ledford H
    Nature; 2014 Apr; 508(7494):24-6. PubMed ID: 24695297
    [No Abstract]   [Full Text] [Related]  

  • 17. Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective.
    Cifaldi L; Locatelli F; Marasco E; Moretta L; Pistoia V
    Trends Mol Med; 2017 Dec; 23(12):1156-1175. PubMed ID: 29133133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-interleukin 2 fusion proteins: a new approach to cancer therapy.
    Reisfeld RA; Gillies SD
    J Clin Lab Anal; 1996; 10(3):160-6. PubMed ID: 8731505
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural born killers: NK cells drafted into the cancer fight.
    O'Hanlon LH
    J Natl Cancer Inst; 2004 May; 96(9):651-3. PubMed ID: 15126597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of action for immunotherapy drugs].
    Tahara H
    Nihon Rinsho; 2012 Dec; 70(12):2066-72. PubMed ID: 23259376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.